🇺🇸 FDA
Patent

US 9492569

Antibodies that bind integrin alpha-V beta-8

granted A61KA61K2039/505A61K49/00

Quick answer

US patent 9492569 (Antibodies that bind integrin alpha-V beta-8) held by The Regents of the University of California expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K49/00, A61P, A61P1/04